|
Pharmaids Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
209.98 Cr.
|
P/BV
|
3.13
|
Book Value (Rs.)
|
19.04
|
|
52 Week High/Low (Rs.)
|
87/32
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
24/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 14.62 | 0.02 |
| Total Income From Operations | 14.62 | 0.02 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 7.17 | 0.00 |
| Purchase of Traded Goods | 2.43 | 0.02 |
| Increase/Decrease in Stocks | 0.69 | 0.00 |
| Employees Cost | 9.11 | 1.99 |
| Depreciation | 1.82 | 0.03 |
| Other Expenses | 4.08 | 1.94 |
| Total Expenses | 25.29 | 3.98 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -10.67 | -3.96 |
| Other Income | 0.03 | -0.79 |
| P/L Before Interest, Excpt. Items & Tax | -10.64 | -4.74 |
| Interest | 1.08 | 0.00 |
| P/L Before Exceptional Items & Tax | -11.72 | -4.74 |
| Exceptional Items | -0.16 | 0.04 |
| P/L Before Tax | -11.88 | -4.70 |
| Tax | -3.18 | -1.27 |
| P/L After Tax from Ordinary Activities | -8.70 | -3.44 |
| Net Profit/Loss For the Period | -8.70 | -3.44 |
| Net P/L After Minority Interest & Share Of Associates | -8.70 | -3.44 |
| | | |
| Equity Share Capital | 35.27 | 21.44 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | -2.47 | -1.60 |
| Diluted EPS (Rs.) | (2.47) | -1.54 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | -2.47 | -1.60 |
| Diluted EPS (Rs.) | (2.47) | -1.54 |
| | | |
| PBITOE Margin (%) | -72.96 | -19063.71 |
| PBTE Margin (%) | -80.14 | -22854.69 |
| PBT Margin (%) | -81.22 | -22670.84 |
| PAT Margin (%) | -59.50 | -16574.21 |
| PAT After MI And SOA Margin (%) | -59.50 | -16574.21 |
